Multifaceted intervention to promote the regular visiting of patients with diabetes to primary care physicians: Rationale, design and conduct of a cluster-randomized controlled trial. The Japan Diabetes Outcome Intervention Trial-2 study protocol

Diabetology International

Volumn 1, Issue 2, 2010, Pages 83-89

  Izumi, Kazuo ^a   Hayashino, Yasuaki ^b   Yamazaki, Katsuya ^c   Suzuki, Hikari ^c   Ishizuka, Naoki ^d   Kobayashi, Masashi ^c   Noda, Mitsuhiko ^a,d  

^a Japan Foundation for the Promotion of International Medical Research Cooperation   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Diabetes; Dropout; Primary care physician; Quality of diabetes care; Regular medical care

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CONSULTATION; DIABETIC PATIENT; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HEALTH PROMOTION; HEALTH SERVICE; HEALTH SURVEY; INTERVENTION STUDY; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUESTIONNAIRE; SAMPLE SIZE; TELEMEDICINE;

EID: 84862867769     PISSN: 21901678     EISSN: 21901686     Source Type: Journal    
DOI: 10.1007/s13340-010-0015-6     Document Type: Article

References (10)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21(9): 1414-31.
2. Yazaki Y, Kadowaki T. Combating diabetes and obesity in Japan. Nat Med. 2006; 12(1): 73-4.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 837-53.
4. Gæde P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348(5): 383-93.
5. Outline for the Results of the National Health and Nutrition Survey Japan, 2007. http://www. nih. go. jp/eiken/english/research/pdf/nhns2007. pdf. Accessed 1 Sept 2010.
6. Smith DM, Weinberger M, Katz BP. A controlled trial to increase office visits and reduce hospitalizations of diabetic patients. J Gen Intern Med. 1987; 2(4): 232-8.
7. Campbell M, Grimshaw J, Steen N. Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action). J Health Serv Res Policy. 2000; 5(1): 12-6.
8. Campbell MK, Mollison J, Grimshaw JM. Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size. Stat Med. 2001; 20(3): 391-9.
9. Hayes RJ, Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol. 1999; 28(2): 319-26.
10. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 1980; 48(4): 817-38.